CVS Aims to Bring More Biosimilars to Market with Launch of Cordavis Subsidiary
CVS Health has launched a new segment that aims to work with drugmakers to bring additional biosimilars to market. The new, wholly owned subsidiary, called Cordavis, aims to develop a biosimilar portfolio with the goal of expanding access to these drugs across the country. Increased uptake of biosimilars can drive down costs of pricey brand …
CVS Aims to Bring More Biosimilars to Market with Launch of Cordavis Subsidiary Read More »